Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Metadata
Title
Acknowledgement to Referees 2005
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 1/2006
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1115-4

Other articles of this Issue 1/2006

Acta Neuropathologica 1/2006 Go to the issue

Regular Paper

Short-term ischemia usually used for ischemic preconditioning down-regulates central cannabinoid receptors in the gerbil hippocampus

Letter to the Editor

The new WHO classification of human pituitary tumors: comments

Letter to the Editor

The new WHO classification of pituitary tumors: a surgeon’s perspective

Letter to the Editor

2004 World Health Organization classification of pituitary tumors: what is new?

Letter to the Editor

Comments on the WHO 2004 classification of pituitary tumors

Letter to the Editor

Subtyping does matter in pituitary adenomas